Abatement of potent P2Y12 antagonist-based dual antiplatelet therapy after coronary intervention: A network meta-analysis of randomized controlled trials

Overview of attention for article published in Frontiers in Cardiovascular Medicine, January 2023

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 9 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 2,794 followers.

New Research: Abatement of potent P2Y12 antagonist-based dual antiplatelet therapy after coronary intervention: A network meta-analysis of randomized controlled trials: Introduction Dual antiplatelet therapy (DAPT) including prasugrel or… https://t.co/r6k

16 Jan 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.